Mostly positive Natrecor review

The FDA on Thursday released its review of Scios' Natrecor nesiritide recombinant b-type natriuretic peptide (BNP) for acute congestive heart failure, which is to be reviewed on Friday by the Cardiovascular Renal Drugs Advisory Committee. The review was generally positive, although some of the results appeared to be driven by differences among

Read the full 521 word article

How to gain access

Continue reading with a
two-week free trial.